TSRX took out two resistance levels today....we're going higher. Hold tight.
Trius Therapeutics (TSRX) is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. This stock is trading up 7.3% to $5.90 in recent trading.
Today’s Range: $5.49-$5.93
52-Week Range: $4.41-$6.49
Three-Month Average Volume: 482,365
From a technical perspective, TSRX is soaring higher here right above its 200-day moving average of $5.38 with heavy upside volume. This move has started to push shares of TSRX into breakout territory, since it’s taken out some near-term overhead resistance at $5.69. Shares of TSRX are now quickly moving within range of triggering another major breakout trade. That trade will hit if TSRX manages to take out its next major overhead resistance levels at $5.90 to $5.93 with high volume.
Traders should now look for long-biased trades in TSRX as long as it’s trending above $5.69 or today’s low of $5.49, and then once it sustains a move or close above those breakout levels with volume that hits near or above 482,365 shares. If that breakout triggers soon, then TSRX will set up to re-test or possibly take out its next major overhead resistance levels at $6.46 to $6.49. If those levels get taken out with volume then $7.44 to $8 will come into range for shares of TSRX.